Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
 |
|
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Increased asthma medication use in association with ambient fine and ultrafine particles.
Eur. Respir. J. 20, 691-702 (2002)
The association between particulate air pollution and asthma medication use and symptoms was assessed in a panel study of 53 adult asthmatics in Erfurt, Germany in winter 1996/1997. Number concentrations of ultrafine particles, 0.01–0.1 µm in diameter (NC0.01–0.1), mean 17,300·cm−3, and mass concentrations of fine particles 0.01–2.5 µm in diameter (MC0.01–2.5), mean 30.3 µg·m−3, were measured concurrently. They were not highly correlated (r=0.45). The associations between ambient particle concentrations and the prevalence of inhaled β2-agonist, corticosteroid use and asthma symptoms, were analysed separately with logistic regression models, adjusting for trend, temperature, weekend, holidays, and first order autocorrelation of the error. Cumulative exposures over 14 days of ultrafine and fine particles were associated with corticosteroid use. β2-agonist use was associated with 5-day mean NC0.01–0.1 and MC0.01–2.5. The prevalence of asthma symptoms was associated with ambient particle concentrations. The results suggest that reported asthma medication use and symptoms increase in association with particulate air pollution and gaseous pollutants such as nitrogen dioxide.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Asthma symptoms; inhaled ß2-agonists; inhaled corticosteroids; particulate air pollution; wheezing
ISSN (print) / ISBN
0903-1936
e-ISSN
1399-3003
Zeitschrift
European Respiratory Journal
Quellenangaben
Band: 20,
Heft: 3,
Seiten: 691-702
Verlag
European Respiratory Society
Verlagsort
Sheffield
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed